Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Effective desensitization for a strong donor-specific HLA antibody in a case of HLA-mismatched allogeneic hematopoietic cell transplantation.

Misra MK, Xin JJ, Brown NK, Weidner JG, Upchurch RL, Bishop MR, Wool GD, Artz AS, Marino SR.

HLA. 2019 Sep;94(3):307-311. doi: 10.1111/tan.13627. Epub 2019 Aug 6.

PMID:
31314169
2.

A Clinician's Guide to Celiac Disease HLA Genetics.

Brown NK, Guandalini S, Semrad C, Kupfer SS.

Am J Gastroenterol. 2019 Oct;114(10):1587-1592. doi: 10.14309/ajg.0000000000000310.

PMID:
31274511
3.

HLA alleles and haplotypes observed in 263 US families.

Osoegawa K, Mallempati KC, Gangavarapu S, Oki A, Gendzekhadze K, Marino SR, Brown NK, Bettinotti MP, Weimer ET, Montero-Martín G, Creary LE, Vayntrub TA, Chang CJ, Askar M, Mack SJ, Fernández-Viña MA.

Hum Immunol. 2019 Sep;80(9):644-660. doi: 10.1016/j.humimm.2019.05.018. Epub 2019 Jun 27.

PMID:
31256909
4.

Creating three dimensional models of the right ventricular outflow tract: influence of contrast, sequence, operator, and threshold.

Burkhardt BEU, Brown NK, Carberry JE, Velasco Forte MN, Byrne N, Greil G, Hussain T, Tandon A.

Int J Cardiovasc Imaging. 2019 Nov;35(11):2067-2076. doi: 10.1007/s10554-019-01646-1. Epub 2019 Jun 15.

PMID:
31203535
5.

Quality control project of NGS HLA genotyping for the 17th International HLA and Immunogenetics Workshop.

Osoegawa K, Vayntrub TA, Wenda S, De Santis D, Barsakis K, Ivanova M, Hsu S, Barone J, Holdsworth R, Diviney M, Askar M, Willis A, Railton D, Laflin S, Gendzekhadze K, Oki A, Sacchi N, Mazzocco M, Andreani M, Ameen R, Stavropoulos-Giokas C, Dinou A, Torres M, Dos Santos Francisco R, Serra-Pages C, Goodridge D, Balladares S, Bettinotti MP, Iglehart B, Kashi Z, Martin R, Saw CL, Ragoussis J, Downing J, Navarrete C, Chong W, Saito K, Petrek M, Tokic S, Padros K, Beatriz Rodriguez M, Zakharova V, Shragina O, Marino SR, Brown NK, Shiina T, Suzuki S, Spierings E, Zhang Q, Yin Y, Morris GP, Hernandez A, Ruiz P, Khor SS, Tokunaga K, Geretz A, Thomas R, Yamamoto F, Mallempati KC, Gangavarapu S, Kanga U, Tyagi S, Marsh SGE, Bultitude WP, Liu X, Cao D, Penning M, Hurley CK, Cesbron A, Mueller C, Mytilineos J, Weimer ET, Bengtsson M, Fischer G, Hansen JA, Chang CJ, Mack SJ, Creary LE, Fernandez-Viña MA.

Hum Immunol. 2019 Apr;80(4):228-236. doi: 10.1016/j.humimm.2019.01.009. Epub 2019 Feb 6. Review.

6.

Nanotechnology in cell replacement therapies for type 1 diabetes.

Ernst AU, Bowers DT, Wang LH, Shariati K, Plesser MD, Brown NK, Mehrabyan T, Ma M.

Adv Drug Deliv Rev. 2019 Jan 15;139:116-138. doi: 10.1016/j.addr.2019.01.013. Epub 2019 Feb 2. Review.

PMID:
30716349
7.

Reanalysis of the role of pronase treatment of B cells in the flow cytometric crossmatch assay: Fc receptor is not the primary target.

Brown NK, Meade JR, Wang J, Marino SR.

Hum Immunol. 2017 Nov;78(11-12):704-709. doi: 10.1016/j.humimm.2017.10.002. Epub 2017 Oct 5.

PMID:
28987959
8.

EDTA is superior to DTT treatment for overcoming the prozone effect in HLA antibody testing.

Wang J, Meade JR, Brown NK, Weidner JG, Marino SR.

HLA. 2017 Feb;89(2):82-89. doi: 10.1111/tan.12950.

PMID:
28102038
9.

Identification and characterization of novel HLA alleles: Utility of next-generation sequencing methods.

Brown NK, Kheradmand T, Wang J, Marino SR.

Hum Immunol. 2016 Apr;77(4):313-6. doi: 10.1016/j.humimm.2016.01.001. Epub 2016 Jan 4.

PMID:
26763581
10.

The Essential Role of Circulating Thyroglobulin in Maintaining Dominance of Natural Regulatory T Cell Function to Prevent Autoimmune Thyroiditis.

Kong YM, Brown NK, Morris GP, Flynn JC.

Horm Metab Res. 2015 Sep;47(10):711-20. doi: 10.1055/s-0035-1548872. Epub 2015 Jul 9. Review.

PMID:
26158397
11.

Staphylococcus aureus retropharyngeal abscess in children.

Brown NK, Hulten KG, Mason EO, Kaplan SL.

Pediatr Infect Dis J. 2015 Apr;34(4):454-6. doi: 10.1097/INF.0000000000000599.

PMID:
25760568
12.

CD160 is essential for NK-mediated IFN-γ production.

Tu TC, Brown NK, Kim TJ, Wroblewska J, Yang X, Guo X, Lee SH, Kumar V, Lee KM, Fu YX.

J Exp Med. 2015 Mar 9;212(3):415-29. doi: 10.1084/jem.20131601. Epub 2015 Feb 23.

13.

Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1.

Chen GY, Brown NK, Wu W, Khedri Z, Yu H, Chen X, van de Vlekkert D, D'Azzo A, Zheng P, Liu Y.

Elife. 2014 Sep 3;3:e04066. doi: 10.7554/eLife.04066.

14.

Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity.

Chen GY, Brown NK, Zheng P, Liu Y.

Glycobiology. 2014 Sep;24(9):800-6. doi: 10.1093/glycob/cwu068. Epub 2014 Jul 4. Review.

15.

Perivascular adipose tissue in vascular function and disease: a review of current research and animal models.

Brown NK, Zhou Z, Zhang J, Zeng R, Wu J, Eitzman DT, Chen YE, Chang L.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1621-30. doi: 10.1161/ATVBAHA.114.303029. Epub 2014 May 15. Review.

16.

Efficacy of HLA-DRB1∗03:01 and H2E transgenic mouse strains to correlate pathogenic thyroglobulin epitopes for autoimmune thyroiditis.

Kong YC, Brown NK, Flynn JC, McCormick DJ, Brusic V, Morris GP, David CS.

J Autoimmun. 2011 Sep;37(2):63-70. doi: 10.1016/j.jaut.2011.05.010. Epub 2011 Jun 17.

17.

The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity.

Park S, Jiang Z, Mortenson ED, Deng L, Radkevich-Brown O, Yang X, Sattar H, Wang Y, Brown NK, Greene M, Liu Y, Tang J, Wang S, Fu YX.

Cancer Cell. 2010 Aug 9;18(2):160-70. doi: 10.1016/j.ccr.2010.06.014.

18.

Direct and indirect roles of the LTbetaR pathway in central tolerance induction.

Zhu M, Brown NK, Fu YX.

Trends Immunol. 2010 Sep;31(9):325-31. doi: 10.1016/j.it.2010.06.005. Epub 2010 Aug 2.

19.

Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function.

Kong YC, Morris GP, Brown NK, Yan Y, Flynn JC, David CS.

J Autoimmun. 2009 Nov-Dec;33(3-4):239-46. doi: 10.1016/j.jaut.2009.09.004. Epub 2009 Oct 12. Review.

20.

B and T lymphocyte attenuator tempers early infection immunity.

Sun Y, Brown NK, Ruddy MJ, Miller ML, Lee Y, Wang Y, Murphy KM, Pfeffer K, Chen L, Kaye J, Fu YX.

J Immunol. 2009 Aug 1;183(3):1946-51. doi: 10.4049/jimmunol.0801866. Epub 2009 Jul 8.

21.
22.

A novel H2A-E+ transgenic model susceptible to human but not mouse thyroglobulin-induced autoimmune thyroiditis: identification of mouse pathogenic epitopes.

Brown NK, McCormick DJ, Brusic V, David CS, Kong YC.

Cell Immunol. 2008 Jan;251(1):1-7. doi: 10.1016/j.cellimm.2008.02.002. Epub 2008 Apr 14.

23.
24.

Clinical judgments of high-risk behavior during recovery.

Brown NK.

J Psychoactive Drugs. 2000 Jul-Sep;32(3):299-304.

PMID:
11061681
25.
26.

Metabolite profiling study of propranolol in rat using LC/MS/MS analysis.

Beaudry F, Yves Le Blanc JC, Coutu M, Ramier I, Moreau JP, Brown NK.

Biomed Chromatogr. 1999 Aug;13(5):363-9.

PMID:
10425029
28.

Nontreatment and aggressive narcotic therapy among hospitalized pancreatic cancer patients.

Brown NK, Thompson DJ, Prentice RL.

J Am Geriatr Soc. 1998 Jul;46(7):839-48.

PMID:
9670870
29.

Mutagenic decomposition products of nitrosated 4-chloroindoles.

Brown NK, Nguyen TT, Taghizadeh K, Wishnok JS, Tannenbaum SR.

Chem Res Toxicol. 1992 Nov-Dec;5(6):797-801.

PMID:
1489931
30.

Serum proteolytic activity during the growth of C6 astrocytoma.

Vaithilingam IS, McDonald W, Brown NK, Stroude E, Cook RA, Del Maestro RF.

J Neurosurg. 1992 Oct;77(4):595-600.

PMID:
1326613
31.

Comparative in vitro metabolism of the cannabinoids.

Harvey DJ, Brown NK.

Pharmacol Biochem Behav. 1991 Nov;40(3):533-40.

PMID:
1806943
32.
33.

In vitro metabolism of the equatorial C11-methyl isomer of hexahydrocannabinol in several mammalian species.

Harvey DJ, Brown NK.

Drug Metab Dispos. 1991 May-Jun;19(3):714-6. No abstract available.

PMID:
1680642
34.
35.
36.

In vitro metabolism of cannabichromene in seven common laboratory animals.

Brown NK, Harvey DJ.

Drug Metab Dispos. 1990 Nov-Dec;18(6):1065-70.

PMID:
1981514
39.

In vitro metabolism of cannabigerol in several mammalian species.

Harvey DJ, Brown NK.

Biomed Environ Mass Spectrom. 1990 Sep;19(9):545-53.

PMID:
2224182
40.

In vitro metabolism of cannabinol in rat, mouse, rabbit, guinea pig, hamster, gerbil and cat.

Brown NK, Harvey DJ.

Eur J Drug Metab Pharmacokinet. 1990 Jul-Sep;15(3):253-8.

PMID:
2253656
41.

Microsomal metabolism of the 1",1"-dimethylheptyl analogue of cannabidiol: relative percentage of monohydroxy metabolites in four species.

Samara E, Brown NK, Harvey DJ.

Drug Metab Dispos. 1990 Jul-Aug;18(4):548-9. No abstract available.

PMID:
1976083
42.

A method for the structural determination of cannabichromene metabolites by mass spectrometry.

Harvey DJ, Brown NK.

Rapid Commun Mass Spectrom. 1990 Apr;4(4):135-6.

PMID:
2134342
43.
44.

Metabolism of n-hexyl-homologues of delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in the mouse.

Brown NK, Harvey DJ.

Eur J Drug Metab Pharmacokinet. 1988 Jul-Sep;13(3):165-76.

PMID:
2853671
46.

In vivo metabolism of the n-propyl homologues of delta-8- and delta-9-tetrahydrocannabinol in the mouse.

Brown NK, Harvey DJ.

Biomed Environ Mass Spectrom. 1988 Apr 1;15(7):403-10.

PMID:
2839261
48.

Factors affecting place of death in Washington State, 1968-1981.

Polissar L, Severson RK, Brown NK.

J Community Health. 1987 Spring;12(1):40-55.

PMID:
3584537
49.

Nontreatment of fever in extended-care facilities.

Brown NK, Thompson DJ.

N Engl J Med. 1979 May 31;300(22):1246-50.

PMID:
431683
50.

Neoplastic diathesis of patients with carcinoid. Report of a case with four other neoplasms.

Brown NK, Smith MP.

Cancer. 1973 Jul;32(1):216-22. No abstract available.

PMID:
4716775

Supplemental Content

Loading ...
Support Center